KEY TAKEAWAY: GSK and Novartis have gone to the outside to hire senior digital marketing people with CPG experience. While these moves are long overdue is it enough or is pharma waiting at the airport for their ship to come in?
Category Archive: As I See It
KEY TAKEAWAY: The US market for major depressive disorders will rise from $2.4 billion in 2015 to $4.6 billion in 2025. Rexulti, I believe, is doing a great job trying to reach new patients with a great creative TV spot.
The pharma industry has been good to me and my wife. It has provided a good living and allowed me to grow professionally and personally. Yet, as an Editor for PM360 and working on a consulting team I have been challenged to either remain quiet when I see clients, focusing too much on things that aren’t important to patients versus listening to our audience at a time when a lot of people are going to need good healthcare.
KEY SUMMARY: You can’t understand what it’s like to be a patient until you’re a patient.
Big pharma shows no sign of wanting to change or implementing change to meet the new challenges of a changing healthcare environment.
KEY TAKEAWAY: Digital marketing is not a bunch of tactics, but rather a way to think about how patients are making healthcare decisions.
KEY TAKEAWAY: [inlinetweet prefix=”” tweeter=”” suffix=””]Tech mania is resurgent when it comes to mobile health[/inlinetweet]. Investors are again, glancing at a clock with no hands — and dismissing the risk. Nobody wants to be left behind in case the next “facebook” of health should appear, but the recent sale of WebMD should be a warning that there is a lot of money to be lost in the mobile health market.
“Sharon was given a few months to live. One year later, she’s here to tell her story”. That’s the headline of the print ad for Merck’s Keytruda and Oncologists are not happy with it.